RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Amr Soliman to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Amr Soliman has written about Antineoplastic Agents.
Amr Soliman
Connection Strength
0.068
Antineoplastic Agents
  1. Elzarkaa AA, Sabaa BE, Abdelkhalik D, Mansour H, Melis M, Shaalan W, Farouk M, Malik E, Soliman AA. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study. J Cancer Res Clin Oncol. 2016 May; 142(5):949-58.
    View in: PubMed
    Score: 0.068
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support